Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,661,526	67,544,126	54,092,240	58,433,854	59,746,995	54,652,290
Market Cap Growth	24.87%	24.87%	-7.43%	-2.20%	9.32%	90.76%
Enterprise Value	74,816,477	67,525,830	54,470,492	57,778,382	59,669,232	54,358,190
Last Close Price	1049000.00	949000.00	760000.00	821000.00	893509.47	817318.74
PE Ratio	68.92	62.35	63.07	73.22	151.80	226.80
Forward PE	57.43	62.18	60.08	82.37	112.20	-
PS Ratio	16.42	14.85	14.64	19.47	38.10	46.92
PB Ratio	6.85	6.19	5.50	6.50	11.97	11.88
P/TBV Ratio	9.41	8.52	8.23	10.14	12.05	11.95
P/FCF Ratio	209.91	189.90	80.60	-	1235.91	875.48
P/OCF Ratio	45.00	40.71	32.46	61.31	131.43	270.44
PEG Ratio	2.99	3.19	3.45	3.32	3.45	-
EV/Sales Ratio	16.45	14.85	14.74	19.25	38.05	46.67
EV/EBITDA Ratio	38.93	35.19	33.97	44.72	85.35	124.54
EV/EBIT Ratio	56.56	51.15	48.91	58.74	111.05	185.66
EV/FCF Ratio	210.35	189.85	81.16	-	1234.30	870.77
Debt / Equity Ratio	0.14	0.14	0.19	0.28	0.26	0.17
Debt / EBITDA Ratio	0.77	0.77	1.19	1.95	1.85	1.80
Debt / FCF Ratio	4.18	4.18	2.85	-	26.74	12.57
Asset Turnover	0.27	0.27	0.23	0.24	0.22	0.19
Inventory Turnover	0.83	0.83	0.76	0.91	1.02	1.37
Quick Ratio	0.35	0.35	0.50	0.76	1.24	1.45
Current Ratio	1.43	1.43	1.33	1.54	2.55	2.97
Return on Equity (ROE)	10.45%	10.45%	9.12%	11.42%	8.21%	5.38%
Return on Assets (ROA)	4.94%	4.94%	4.27%	5.01%	4.67%	2.97%
Return on Capital (ROIC)	6.84%	6.84%	5.99%	6.91%	5.76%	3.52%
Return on Capital Employed (ROCE)	9.80%	9.80%	9.40%	7.90%	7.80%	5.00%
Earnings Yield	145.10%	1.60%	1.59%	1.37%	0.66%	0.44%
FCF Yield	47.64%	0.53%	1.24%	-0.01%	0.08%	0.11%
Buyback Yield / Dilution	-	-	-1.95%	-5.51%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.